Literature DB >> 16008585

Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin.

Emmanuelle Coutanceau1, Laurent Marsollier, Roland Brosch, Emmanuelle Perret, Pierre Goossens, Myriam Tanguy, Stewart T Cole, Pamela L C Small, Caroline Demangel.   

Abstract

Mycobacterium ulcerans (Mu), the aetiological agent of Buruli ulcer, is an extracellular pathogen producing the macrolide toxin mycolactone. Using a mouse model of intradermal infection, we found that Mu was initially captured by phagocytes and transported to draining lymph nodes (DLN) within host cells. Similar to Buruli ulcers in humans, the infection site eventually became ulcerated with tissue necrosis and extracellular bacteria, at later stages. In contrast to Mycobacterium bovis BCG (BCG), Mu did not disseminate to the spleen. However, mice infected with Mu or BCG developed comparable primary cellular responses to mycobacterial antigens in DLN and spleen. The role of mycolactone in this sequence of events was examined with a mycolactone-deficient (mup045) mutant of Mu. Mup045 bacilli were better internalized than wild-type (wt) bacteria by mouse phagocytes in vitro. Moreover, infection with wt but not mup045 Mu led to inhibition of TNF-alpha expression, upregulation of MIP-2 chemokine, and host cell death within 1 day. Our results suggest that mycolactone expression during the intracellular life of Mu may contribute to immune evasion by inhibiting phagocytosis, provoking apoptosis of antigen presenting cells and altering the establishment of an appropriate inflammatory reaction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16008585     DOI: 10.1111/j.1462-5822.2005.00546.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  66 in total

1.  Chemotherapy-associated changes of histopathological features of Mycobacterium ulcerans lesions in a Buruli ulcer mouse model.

Authors:  Marie-Thérèse Ruf; Daniela Schütte; Aurélie Chauffour; Vincent Jarlier; Baohong Ji; Gerd Pluschke
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

2.  Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression.

Authors:  Alexandra G Fraga; Andrea Cruz; Teresa G Martins; Egídio Torrado; Margarida Saraiva; Daniela R Pereira; Wayne M Meyers; Françoise Portaels; Manuel T Silva; António G Castro; Jorge Pedrosa
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

3.  Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcer.

Authors:  Timothy P Stinear; Torsten Seemann; Sacha Pidot; Wafa Frigui; Gilles Reysset; Thierry Garnier; Guillaume Meurice; David Simon; Christiane Bouchier; Laurence Ma; Magali Tichit; Jessica L Porter; Janine Ryan; Paul D R Johnson; John K Davies; Grant A Jenkin; Pamela L C Small; Louis M Jones; Fredj Tekaia; Françoise Laval; Mamadou Daffé; Julian Parkhill; Stewart T Cole
Journal:  Genome Res       Date:  2007-01-08       Impact factor: 9.043

Review 4.  Pathogenesis of skin ulcers: lessons from the Mycobacterium ulcerans and Leishmania spp. pathogens.

Authors:  Laure Guenin-Macé; Reid Oldenburg; Fabrice Chrétien; Caroline Demangel
Journal:  Cell Mol Life Sci       Date:  2014-01-21       Impact factor: 9.261

5.  Use of the immunodominant 18-kiloDalton small heat shock protein as a serological marker for exposure to Mycobacterium ulcerans.

Authors:  Diana Diaz; Heinz Döbeli; Dorothy Yeboah-Manu; Ernestina Mensah-Quainoo; Arno Friedlein; Nicole Soder; Simona Rondini; Thomas Bodmer; Gerd Pluschke
Journal:  Clin Vaccine Immunol       Date:  2006-10-04

6.  Evidence for an intramacrophage growth phase of Mycobacterium ulcerans.

Authors:  Egídio Torrado; Alexandra G Fraga; António G Castro; Pieter Stragier; Wayne M Meyers; Françoise Portaels; Manuel T Silva; Jorge Pedrosa
Journal:  Infect Immun       Date:  2006-12-04       Impact factor: 3.441

Review 7.  Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans.

Authors:  Caroline Demangel; Timothy P Stinear; Stewart T Cole
Journal:  Nat Rev Microbiol       Date:  2009-01       Impact factor: 60.633

8.  Differences in virulence and immune response induced in a murine model by isolates of Mycobacterium ulcerans from different geographic areas.

Authors:  R Hurtado Ortiz; D Aguilar Leon; H Orozco Estevez; A Martin; J Luna Herrera; L Flores Romo; F Portaels; R Hernandez Pando
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

9.  Mycolactone gene expression is controlled by strong SigA-like promoters with utility in studies of Mycobacterium ulcerans and buruli ulcer.

Authors:  Nicholas J Tobias; Torsten Seemann; Sacha J Pidot; Jessica L Porter; Laurent Marsollier; Estelle Marion; Franck Letournel; Tasnim Zakir; Joseph Azuolas; John R Wallace; Hui Hong; John K Davies; Benjamin P Howden; Paul D R Johnson; Grant A Jenkin; Timothy P Stinear
Journal:  PLoS Negl Trop Dis       Date:  2009-11-24

10.  Ongoing genome reduction in Mycobacterium ulcerans.

Authors:  Simona Rondini; Michael Käser; Timothy Stinear; Michel Tessier; Cyrill Mangold; Gregor Dernick; Martin Naegeli; Françoise Portaels; Ulrich Certa; Gerd Pluschke
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.